ESRD: Clinical Trials

6 trials for ESRD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 26Completed 6
Phase 11Completed 1

Follow ESRD: new trials by email Literature Review of ESRD trials Research Report on ESRD

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effects of Patiromer on Serum Potassium Level and Gut Microbiome of ESRD Patients With Hyperkalemia
Patiromer - ESRD, Hyperkalemia
Phase 2CompletedDominic Raj272017-11-012023-05-09
Effect of SNF472 on Progression of Cardiovascular Calcification in End-Stage-Renal-Disease (ESRD) Patients on Hemodialysis (HD)
SNF472, Placebo - Cardiovascular Diseases, Cardiovascular Abnormalities
Phase 2CompletedSanifit Therapeutics S. A.2742016-11-012021-04-15
Apixaban in End-stage Kidney Disease : A Pharmacokinetics Study
apixaban - ESRD, Anticoagulant Toxicity
Phase 2CompletedUniversitaire Ziekenhuizen KU Leuven242016-09-252018-10-17
Nutrition, Inflammation and Insulin Resistance in End Stage Renal Disease-Aim 2
anakinra, actos, placebo - ESRD
Phase 2CompletedVA Office of Research and Development332014-10-222025-02-06
Pharmacodynamic Study of AZD1722 in End-stage Renal Disease Patients on Hemodialysis
AZD1722 (in-patient), Placebo (in-patient), AZD1722 (out-patient) - End Stage Renal Disease, Chronic Kidney Disease Stage 5
Phase 2CompletedArdelyx882013-01-012020-08-10
Use of a Lifeline Graft in the A-V Shunt Model
Lifeline - ESRD, Hemodialysis
Phase 1 / Phase 2CompletedCytograft Tissue Engineering2004-09-012013-07-17

Narrower conditions

Kidney Failure, Chronic (6)  ·  Calcinosis (1)  ·  Cardiovascular Abnormalities (1)  ·  Cardiovascular Diseases (1)  ·  Hyperkalemia (1)  ·  Renal Insufficiency, Chronic (1)  ·  Vascular Calcification (1)

Broader conditions

Chronic Disease (6)  ·  Disease Attributes (6)  ·  Female Urogenital Diseases (6)  ·  Female Urogenital Diseases and Pregnancy Complications (6)  ·  Kidney Diseases (6)  ·  Male Urogenital Diseases (6)  ·  Pathologic Processes (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Renal Insufficiency (6)  ·  Urogenital Diseases (6)  ·  Urologic Diseases (6)  ·  Renal Insufficiency, Chronic (5)  ·  Metabolic Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Calcium Metabolism Disorders (1)

Interventions

Blood Vessel Prosthesis (1)  ·  Interleukin 1 Receptor Antagonist Protein (1)  ·  Pioglitazone (1)  ·  SNF472 (1)  ·  apixaban (1)  ·  patiromer (1)  ·  tenapanor (1)

Sponsors

Ardelyx (1)  ·  Cytograft Tissue Engineering (1)  ·  Dominic Raj (1)  ·  Sanifit Therapeutics S. A. (1)  ·  Universitaire Ziekenhuizen KU Leuven (1)  ·  VA Office of Research and Development (1)

Countries

United States (4)  ·  Argentina (1)  ·  Belgium (1)  ·  Poland (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Alex Gold, MD (1)  ·  David P Rosenbaum, PhD (1)  ·  Lech Cierpka, MD PhD (1)  ·  Talat A Ikizler, MD (1)

Results publications

PMID 31707860, PMID 32750456, PMID 33835939, PMID 38178557, PMID 38384289

NIH funding

2015 (1), R44HL064462 (1)